Recruiting NA INTERVENTIONAL 3-arm
NCT07089173
The Effect-site Concentration of Remifentanil Blunting Endotracheal Intubation Responses During Anesthesia Induction With Lidocaine or Sufentanil Combined With Etomidate: A Randomized Controlled Study
Sponsor: Peking University Shenzhen Hospital
Conditions
Hemodynamics
Updated 3 times since 2025 Last updated: Sep 17, 2025 Started: Aug 1, 2025 Primary completion: Jul 30, 2026 Completion: Jul 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07089173, this NA trial focuses on Hemodynamics and remains actively recruiting participants. Sponsored by Peking University Shenzhen Hospital, it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
3 versions recorded-
Oct 2025 — Present [monthly]
Recruiting NA
-
Sep 2025 — Oct 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Aug 2025 — Sep 2025 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Peking University Shenzhen Hospital
Data source: Peking University Shenzhen Hospital
For direct contact, visit the study record on ClinicalTrials.gov .